Home > Insider Trading > Filing (0001567619-21-020595)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1505497	Biorestorative Therapies Inc.	BRTX	Services-Misc Health & Allied Services, Nec (8090)	911835664

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1756228	Lance Alstodt	C/O Biorestorative Therapies, Inc. 40 Marcus Drive, Suite 1 Melville NY 11747	President, Ceo, Cob	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-11-16	1,000	$6.76	152,418	No	4	P	Direct
Common Stock	Acquisiton	2021-11-16	1,800	$6.87	154,218	No	4	P	Direct
Common Stock	Acquisiton	2021-11-16	200	$6.55	154,418	No	4	P	Direct
Common Stock	Acquisiton	2021-11-16	1,500	$6.51	155,918	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option	$13.50		2031-03-18	293,479	293,479	Direct
Common Stock	Stock Option	$13.50		2031-11-04	42,059	42,059	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2031-03-18	293,479	293,479	Direct
2031-11-04	42,059	42,059	Direct

Footnotes

The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.74 to $6.77, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
Includes 146,740 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 48,914 shares on March 18, 2022 and 48,913 shares on each of March 18, 2023 and March 18, 2024.
The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 with the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022.